S. Song et al. / Tetrahedron 64 (2008) 5728–5735
5733
4.2. General procedure for the preparation of 4-aryl-2-
hydroxy-3-(thien-2-oyl)-2-(trifluoromethyl)-3,4,7,8-
tetrahydro-2H-chromen-5(6H)-one (4a–4j)
2H), 2.73–2.81 (s, 6H), 4.01–4.09 (m, 2H), 6.42–6.45 (m, 2H), 6.88–
6.90 (m, 3H), 7.51–7.53 (m, 1H), 7.85–7.88 (m, 1H), 8.62–8.66 (m,
1H); 19F NMR (DMSO-d6, 282 MHz):
d
ꢀ80.64 (s, 3F); IR (KBr) nmax
:
3432, 3090, 2961, 2792, 1662, 1609, 1520, 1452, 1418, 1377, 1358,
To a mixture of aryldehyde 1 (1.5 mmol), 1,3-cyclohexanaedione
2 (168 mg, 1.5 mmol), and 4,4,4-trifluoro-1-(thien-2-yl)butane-1,3-
dione 3 (333 mg, 1.5 mmol) in 12 mL EtOH was added 0.3 mmol of
Et3N as catalyst under stirring at room temperature. The mixture
was refluxed and continuously stirred for specified hour (moni-
tored by TLC). After cooling, the resulting solid was filtered, washed
with 10–15 mL of cold EtOH and air-dried to afford the crude
product. The pure product was obtained by recrystallization from
ethanol.
1071, 820, 745 cmꢀ1; MS (ESI) m/z: [(MþH)þ, 466.2], [(Mþ2H)þ,
467.3]; HRMS for
466.1294.
C
23H23NO4F3Sþ1 Calcd: 466.1300; Found:
4.2.6. 4-(4-Chlorophenyl)-2-hydroxy-3-(thien-2-oyl)-2-
(trifluoromethyl)-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4f)
White solid; mp 224–225 ꢁC; 1H NMR (DMSO-d6, 300 MHz):
d
1.83–2.05 (m, 2H), 2.15–2.25 (m. 2H), 2.37–2.61 (m, 2H), 4.10–4.14
(m, 2H), 7.03–7.24 (m, 5H), 7.50–7.60 (m, 1H), 7.89–7.92 (m, 1H),
8.78–8.82 (m, 1H); 19F NMR (DMSO-d6, 282 MHz):
d
ꢀ80.58 (s, 3F);
4.2.1. 2-Hydroxy-4-phenyl-3-(thien-2-oyl)-2-(trifluoromethyl)-
3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4a)
IR (KBr) nmax: 3444, 1657, 1607, 1519, 1493, 1417, 1374, 1073, 810,
727 cmꢀ1; MS (ESI) m/z: [(MþH)þ, 459.0/457.0]; Anal. Calcd for
White solid; mp 222–223 ꢁC; 1H NMR (DMSO-d6, 300 MHz):
C21H16ClF3O4S: C, 55.21; H, 3.53. Found: C, 54.88; H, 3.58.
d
1.91–1.94 (m, 2H), 2.15–2.19 (m, 2H), 2.60–2.63 (m, 2H), 4.06 (s,
1H), 4.13 (s, 1H), 6.93–7.25 (m, 6H), 7.45–7.48 (m, 1H), 7.83–7.88 (m,
1H), 8.74–8.77 (m, 1H); 19F NMR (DMSO-d6, 282 MHz):
4.2.7. 2-Hydroxy-4-(4-nitrophenyl)-3-(thien-2-oyl)-2-
d
ꢀ80.66 (s,
(trifluoromethyl)-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4g)
3F); IR (KBr) nmax: 3431, 3100, 2789, 1702, 1659, 1609, 1520, 1496,
1457, 1418, 1360, 1077, 729 cmꢀ1; MS (70 eV, EI) m/z (%): 422 (Mþ,
3.13), 311 [(MꢀC5H3OS)þ, 15.00], 222 (C8H5F3O2Sþ, 25.06), 199
(C13H11Oþ2 , 100), 69 (CF3þ, 31.34); Anal. Calcd for C21H17F3O4S: C,
59.71; H, 4.06. Found: C, 59.57; H, 3.93.
White solid; mp 230–231 ꢁC; 1H NMR (DMSO-d6, 300 MHz):
d
1.96–1.98 (m, 2H), 2.18–2.25 (m, 2H), 2.46–2.57 (m, 2H), 4.25–4.27
(m, 2H), 7.02 (s, 1H), 7.43 (d, J¼8.6 Hz, 2H), 7.64–7.66 (m, 1H), 7.90–
7.94 (m, 1H), 7.95 (d, J¼8.6 Hz, 2H), 8.98–9.00 (m, 1H); 19F NMR
(DMSO-d6, 282 MHz):
d
ꢀ80.92 (s, 3F); IR (KBr) nmax: 3430, 3078,
2792, 1655,1606,1520, 1458,1416, 1074, 806, 760 cmꢀ1; MS (ESI) m/
z: [(MþH)þ, 468.0], [(Mþ2H)þ, 469.0], [(MþHþH2O)þ, 486.7]; Anal.
Calcd for C21H16F3NO6S: C, 53.96; H, 3.45; N, 3.00. Found: C, 53.91;
H, 3.71; N, 2.70.
4.2.2. 2-Hydroxy-3-(thien-2-oyl)-4-p-tolyl-2-(trifluoromethyl)-
3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4b)
White solid; mp 216–218 ꢁC; 1H NMR (CDCl3, 300 MHz):
d 2.02–
2.10 (m, 2H), 2.16 (s, 3H), 2.28–2.38 (m, 2H), 2.58–2.66(m, 2H), 3.80
(d, J¼11.7 Hz, 1H), 4.03 (d, J¼11.7 Hz, 1H), 6.33 (br s, 1H), 6.87–7.01
4.2.8. 2-Hydroxy-4-(3-nitrophenyl)-3-(thien-2-oyl)-2-
(m, 6H), 7.64 (m, 1H); 19F NMR (DMSO-d6, 282 MHz):
d
ꢀ83.43 (s,
(trifluoromethyl)-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4h)
CF3); IR (KBr) nmax: 3305, 3090, 3032, 2968, 2878, 1662, 1606, 1519,
1458, 1419, 1377, 1073, 816, 752 cmꢀ1; MS (70 eV, EI) m/z (%): 436
(Mþ, 1.65), 325 [(MꢀC5H3OS)þ, 10.48], 222 (C8H5F3O2Sþ, 9.43), 199
(C13H11Oþ2 , 100), 69 (CF3þ, 13.12); Anal. Calcd for C22H19F3O4S: C,
60.54; H, 4.39. Found: C, 60.38; H, 4.24.
Light yellow solid; mp 236–237 ꢁC; 1H NMR (DMSO-d6,
300 MHz):
d 1.97–1.98 (m, 2H), 2.22–2.28 (m, 2H), 2.44–2.66 (m,
2H), 4.28 (br s, 2H), 7.00 (s, 1H), 7.36–7.39 (m, 1H), 7.57–7.68 (m,
2H), 7.85–8.00 (m, 3H), 8.90–8.95 (m, 1H); 19F NMR (DMSO-d6,
282 MHz):
d
ꢀ80.54 (s, 3F); IR (KBr) nmax: 3298, 3097, 2970, 2895,
2785, 2584, 2005, 1944, 1885, 1840, 1763, 1660, 1609, 1500, 1481,
1457, 1417, 1077, 750, 690, 711 cmꢀ1; MS (70 eV, EI) m/z (%): 467
(Mþ, 5.83), 356 [(MꢀC5H3OS)þ, 17.24], 245 [(MꢀC8H5F3O2S)þ,
32.15], 228 (C13H10NOþ3 ,100), 222 (C8H5F3O2Sþ, 95.90), 199
(C13H11Oþ2 , 45.17), 153 (C7H5O2Sþ, 94.29), 111 (C5H3OSþ,78.45), 69
(CFþ3 ,96.79); Anal. Calcd for C21H16F3NO6S: C, 53.96; H, 3.45; N, 3.00.
Found: C, 53.89; H, 3.58; N, 2.88.
4.2.3. 2-Hydroxy-4-(4-methoxyphenyl)-3-(thien-2-oyl)-2-
(trifluoromethyl)-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4c)
White solid; mp 226–227 ꢁC; 1H NMR (DMSO-d6, 300 MHz):
d
1.91–1.95 (m, 2H), 2.17–2.21 (m, 2H), 2.48–2.59 (m, 2H), 3.32 (s,
1H), 3.58 (s, 3H), 4.08–4.11 (m, 2H), 6.61–6.65 (m, 2H), 6.96–7.02
(m, 3H), 7.50–7.58 (m, 1H), 7.86–7.88 (m, 1H), 8.65–8.75 (m, 1H); 19
NMR (DMSO-d6, 282 MHz):
F
d
ꢀ80.65 (s, 3F); IR (KBr) nmax: 3431,
3090, 2967, 2835, 1660, 1605, 1513, 1459, 1418, 1375, 1255, 1072,
834 cmꢀ1; MS (ESI) m/z: [(MþH)þ, 453.3], [(MþNa)þ, 475.2],
[(MþK)þ, 491.2]; Anal. Calcd for C22H19F3O5S: C, 58.40; H, 4.23.
Found: C, 58.39; H, 4.03.
4.2.9. 2-Hydroxy-4-(3-phenoxyphenyl)-3-(thien-2-oyl)-2-
(trifluoromethyl)-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4i)
Light yellow solid; mp 196–197 ꢁC; 1H NMR (DMSO-d6,
300 MHz): d 1.90–1.98 (m, 2H), 2.21–2.24 (m, 2H), 2.51 (s, 2H), 4.11
(br s, 2H), 6.59–6.63 (m, 3H), 6.67 (s, 1H), 6.75–6.79 (m, 1H), 7.04–
7.15 (m, 3H), 7.29 (m, 2H), 7.58 (m, 1H), 7.98 (m, 1H), 8.81 (m, 1H);
4.2.4. 2-Hydroxy-4-(4-hydroxyphenyl)-3-(thien-2-oyl)-2-
(trifluoromethyl)-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4d)
White solid; mp 203–204 ꢁC; 1H NMR (DMSO-d6, 300 MHz):
19F NMR (DMSO-d6, 282 MHz):
d
ꢀ81.13 (s, 3F); IR (KBr) nmax: 3310,
3040, 2782, 2581, 1660, 1600, 1518, 1480, 1445, 1416, 1357, 1200,
d
1.88–1.92 (m, 2H), 2.15–2.18 (m, 2H), 2.34–2.70 (m, 2H), 3.98–4.07
1070, 750, 727, 708 cmꢀ1
;
MS (ESI) m/z: [(MþH)þ, 515.2],
(m, 2H), 6.43–6.46 (m, 2H), 6.86–7.03 (m, 3H), 7.49–7.56 (m, 1H),
[(Mþ2H)þ, 516.3]; Anal. Calcd for C27H21F3O5S: C, 63.03; H, 4.11.
7.87–7.89 (m, 1H), 8.65–8.70 (m, 1H), 8.95–9.01 (m, 1H); 19F NMR
Found: C, 62.51; H, 4.36.
(DMSO-d6, 282 MHz):
d
ꢀ80.73 (s, 3F); IR (KBr) nmax: 3510, 3430,
3096, 2981, 2768,1664,1655,1605,1517, 1448,1419, 1185, 1072, 805,
745 cmꢀ1; MS (ESI) m/z: [(MþH)þ, 439.3], [(Mþ2H)þ, 440.2],
[(MþNa)þ, 461.0], [(MþK)þ, 477.0], [(MþKþH2O)þ, 493.0]; HRMS
for C21H17 F3O5Sþ1 Calcd: 438.0749; Found: 438.0762.
4.2.10. 4-(3-Bromophenyl)-2-hydroxy-3-(thien-2-oyl)-2-
(trifluoromethyl)-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4j)
Light yellow solid; mp 236–237 ꢁC; 1H NMR (DMSO-d6,
300 MHz):
2H), 4.13 (br s, 2H), 7.03–7.04 (m, 2H), 7.12–7.18 (m, 2H), 7.27–7.30
(m, 1H), 7.61–7.64 (m, 1H), 7.90–7.92 (m, 1H), 8.80–8.85 (m, 1H); 19
NMR (DMSO-d6, 282 MHz):
d 1.95–1.98 (m, 2H), 2.20–2.23 (m, 2H), 2.50–2.56 (m,
4.2.5. 4-(4-(Dimethylamino)phenyl)-2-hydroxy-3-(thien-2-oyl)-2-
(trifluoromethyl)-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (4e)
Light yellow solid; mp 205–207 ꢁC; 1H NMR (DMSO-d6,
F
d
ꢀ80.57 (s, 3F); IR (KBr) nmax: 3436,
3079, 2964, 2891, 1658, 1608, 1518, 1476, 1457, 1416, 1362, 1189, 806,
300 MHz):
d
1.90–1.92 (m, 2H), 2.14–2.18 (m, 2H), 2.44–2.53 (m,
726 cmꢀ1; MS (70 eV, EI) m/z (%): 500 (Mþ, 1.58), 391/389